Euclises Pharmaceuticals, Inc.
Edit

Euclises Pharmaceuticals, Inc.

http://www.euclises.com/
Last activity: 19.01.2017
Categories: DevelopmentDrugManagementMedtechPlatformTechnology
Euclises Pharmaceuticals is developing novel enzyme (COX-2) inhibitors designed to increase the effectiveness of chemotherapy safely
Mentions
15
Total raised: $3.3M

Investors 5

Funding Rounds 2

DateSeriesAmountInvestors
07.04.2015Series A$2M-
09.09.2014Series A$1.3M-

Mentions in press and media 15

DateTitleDescriptionSource
19.01.2017John Talley Turns His Attention to Cancer TherapyFor Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebre...iselectfun...
19.01.2017John Talley Turns His Attention to Cancer TherapyFor Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebre...iselectfun...
09.12.2015Euclises Pharmaceuticals, Inc. Receives Notice of Patent All...ST. LOUIS–(BUSINESS WIRE)–December 9, 2015– Euclises Pharmaceuticals, Inc., a biopharmaceutical com...venturebea...
20.10.2015A Q&A session with Euclises’ John Talley[iSelect] You have the honorable position of being one of the leading medicinal chemists in the worl...iselectfun...
20.10.2015The New American Entrepreneur – EuclisesEuclises is drug discovery and development company targeting some of the deadliest cancers out there...iselectfun...
20.10.2015A Q&A session with Euclises’ John Talley[iSelect] You have the honorable position of being one of the leading medicinal chemists in the worl...iselectfun...
07.04.2015Euclises Completes Financing RoundST. LOUIS–(BUSINESS WIRE)–April 7, 2015– Euclises Pharmaceuticals, Inc., a pharmaceutical company d...venturebea...
07.04.2015Euclises Pharmaceuticals Completes Nearly $2M Series A Fundi...Euclises Pharmaceuticals, Inc., a a St. Louis-based biotechnology company developing third-generatio...finsmes.co...
27.01.2015Euclises Announces Appointment of Bobby Sandage as New CEODevelopment Experience to Drive Entry of Novel COX-2 Inhibitors into Clinical Trials for Cancer ST....venturebea...
20.01.2015BioTech Selection Committee: Bobby SandageSpotlight: Selection Committee Member A Brief Background: Bobby W. Sandage, Jr., Ph.D. has 34 year...iselectfun...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In